Fred Campbell,
Scientific Director
Fred obtained his PhD from the University of Leeds, UK and has 15 years’ experience in the design and evaluation of lipid-based nanomedicines. During this time, he has advanced our fundamental understanding of how lipid-based nanoparticles are recognized and processed within the body and has developed innovative ways to exploit or evade these dominant interactions. Recipient of a Marie Curie fellowship, he has published >25 peer-reviewed articles in high impact journals.
|
|
|
